In the UK, recombinant von Willebrand factor (rVWF; vonicog alfa) is currently indicated for surgical bleeding or the prevention and treatment of haemorrhage in adults with VWD, when desmopressin (DDAVP) alone is ineffective or contraindicated [12]. The gene discussed is VWF; the disease is von Willebrand disease (hereditary or acquired).